medicaid glp-1 More states consider dropping weight loss drugs from • Stateline Have you heard? GLP1 medicines

9.4 Patient-centered outcomes: quantifying shared decision-making as evidence Polycystic Ovary Syndrome face complex trade-offs between body weight, aesthetic distress, fertility goals, psychological burden, and long-term cardiometabolic risks

Microdoses of GLP-1s can cause weight loss, especially when combined with diet and exercise programs

Individuals were excluded if they met any of the following criteria: chronic liver disease other than NAFLD, including alcohol, viral, drug-induced, autoimmune and genetic diseases, liver cirrhosis, or clinical diagnosis of hepatic decompensation (such as oesophageal varices or ascites)

Kanoski SE, Hayes MR, Skibicka KP